Lord Abbett Health Care F3 (LHCOX)

Fund Assets	8.74M
Expense Ratio	0.674%
Min. Investment	$0.00
Turnover	91.00%
Dividend (ttm)	0.08
Dividend Yield	0.35%
Dividend Growth	-23.43%
Payout Frequency	Annual
Ex-Dividend Date	Dec 2, 2025

Previous Close	24.15
YTD Return	5.69%
1-Year Return	15.58%
5-Year Return	25.18%
52-Week Low	20.78
52-Week High	25.44
Beta (5Y)	n/a
Holdings	55
Inception Date	Jul 31, 2019

About LHCOX

Lord Abbett Health Care Fund Class F3 is a mutual fund focused on the health care sector, designed to achieve long-term capital appreciation by investing primarily in equity and equity-related securities of companies involved in health care and biotechnology. The fund typically allocates at least 80% of its assets to health care-related firms, covering industries such as pharmaceuticals, medical devices, health care services, and biotechnology. Its portfolio spans both U.S. and international companies, offering diversified exposure to the global health care market. With 58 holdings as of the latest data, the fund seeks to capture growth opportunities driven by innovation, demographic changes, and advancements in medical technology. The fund has a net expense ratio of 0.68% and does not require a minimum investment. Lord Abbett Health Care Fund Class F3 plays a specialized role in the market by providing investors targeted access to one of the most vital and dynamic sectors of the global economy, aligning with the MSCI ACWI Health Care Index as its benchmark.

• Fund Family: Lord Abbett
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: Nasdaq
• Ticker Symbol: LHCOX
• Share Class: Class F3
• Index: MSCI ACWI/Health Care NR Index

Performance

LHCOX had a total return of 15.58% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.95%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
LHCVX	Class R6	0.68%
LHCIX	Class I	0.78%
LHCFX	Class F	0.78%
LHCTX	Class R5	0.78%

Top 10 Holdings

44.28% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.72%
UnitedHealth Group Incorporated	UNH	5.57%
Johnson & Johnson	JNJ	5.11%
Novartis AG	NOVN	4.32%
Natera, Inc.	NTRA	3.71%
Gilead Sciences, Inc.	GILD	3.64%
CVS Health Corporation	CVS	3.44%
Guardant Health, Inc.	GH	2.69%
Galderma Group AG	GALD	2.68%
Thermo Fisher Scientific Inc.	TMO	2.39%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$0.084	Dec 2, 2025
Nov 26, 2024	$0.1097	Nov 26, 2024
Nov 22, 2022	$0.0471	Nov 22, 2022
Nov 23, 2021	$1.4724	Nov 23, 2021
Nov 24, 2020	$2.3345	Nov 24, 2020
Nov 21, 2019	$0.0104	Nov 21, 2019

Data Sources: Tiingo, Alpha Vantage, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Alpha Vantage. Several fund data points are also provided by Finnhub.

Last checked:

Oct 17, 2026

Data Sources Report a data error